ALX Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALX Oncology and other ETFs, options, and stocks.About ALXO
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications.
CEOJason Lettmann
CEOJason Lettmann
Employees80
Employees80
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees80
Employees80
ALXO Key Statistics
Market cap74.55M
Market cap74.55M
Price-Earnings ratio-0.68
Price-Earnings ratio-0.68
Dividend yield—
Dividend yield—
Average volume169.65K
Average volume169.65K
High today$1.39
High today$1.39
Low today$1.30
Low today$1.30
Open price$1.32
Open price$1.32
Volume147.67K
Volume147.67K
52 Week high$2.27
52 Week high$2.27
52 Week low$0.404
52 Week low$0.404
Stock Snapshot
As of today, ALX Oncology(ALXO) shares are valued at $1.35. The company's market cap stands at 74.55M, with a P/E ratio of -0.68.
As of 2025-12-05, ALX Oncology(ALXO) stock has fluctuated between $1.30 and $1.39. The current price stands at $1.35, placing the stock +3.8% above today's low and -2.9% off the high.
ALX Oncology(ALXO) shares are trading with a volume of 147.67K, against a daily average of 169.65K.
In the last year, ALX Oncology(ALXO) shares hit a 52-week high of $2.27 and a 52-week low of $0.40.
In the last year, ALX Oncology(ALXO) shares hit a 52-week high of $2.27 and a 52-week low of $0.40.
People also own
Based on the portfolios of people who own ALXO. This list is generated using Robinhood data, and it’s not a recommendation.